Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision footer was updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than any change to the specific trial record.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedAdded Revision: v3.5.0 to the version history and removed Revision: v3.4.3.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision entry v3.4.3 was added to the Record History, and the previous v3.4.2 entry was removed.SummaryDifference0.0%

- Check86 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous entry v3.4.1 was removed.SummaryDifference0.0%

- Check93 days agoChange DetectedThe study record history shows an addition of Revision: v3.4.1 and a deletion of Revision: v3.4.0, indicating a minor system/version update. It does not modify study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.